Eagle Pharmaceuticals, Inc.
NASDAQ:EGRX
4.28 (USD) • At close September 18, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -2.666 | 35.642 | -8.627 | 11.989 | 14.313 | 31.903 | 51.943 | 81.453 | 2.571 | -17.977 | -6.048 | -19.383 |
| Afschrijvingen & Amortisatie
| 16.668 | 12.024 | 3.76 | 4.766 | 4.651 | 3.67 | 3.747 | 1.589 | 0.112 | 0.104 | 0.135 | 0.24 |
| Uitgestelde Inkomstenbelasting
| 29.931 | -8.324 | -3.618 | -1.511 | 0.152 | -2.468 | 17.289 | -30.116 | -3.778 | 0 | 1.052 | 0.051 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 16.451 | 19.555 | 24.756 | 21.998 | 19.082 | 15.429 | 9.768 | 4.051 | 0.606 | 0.317 | 0.402 |
| Verandering in Werkkapitaal
| 0.866 | -16.404 | 9.537 | 0.816 | 14.392 | -7.889 | -29.569 | -8.694 | -16.725 | 2.851 | -2.832 | 2.815 |
| Vorderingen
| 0 | -30.832 | 9.529 | -3.113 | 18.481 | -12.665 | -11.627 | -15.919 | -14.311 | -2.172 | -3.543 | -1.32 |
| Voorraden
| 0.866 | -8.339 | -13.833 | -1.509 | 1.739 | -5.556 | -2.379 | 12.303 | -13.8 | -1.294 | 0.087 | 1.052 |
| Crediteuren
| 0 | 2.966 | 10.162 | 0.806 | -4.455 | -2.064 | -8.46 | 10.668 | 0.356 | 2.867 | -0.251 | -0.093 |
| Overig Werkkapitaal
| -0.866 | 19.801 | 3.679 | 4.632 | -1.373 | 12.396 | -7.103 | -15.746 | 11.03 | 3.45 | 0.875 | 3.176 |
| Overige Niet-Contante Posten
| -30.797 | 11.312 | 7.612 | 8.681 | 0.48 | 8.086 | 0.08 | -0.793 | 4.051 | 0.573 | 1.496 | 0.327 |
| Kasstroom uit Operationele Activiteiten
| 30.797 | 50.701 | 28.219 | 49.497 | 55.986 | 52.384 | 58.919 | 53.207 | -9.718 | -13.843 | -5.88 | -15.548 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| 0 | -0.178 | -0.323 | -0.747 | -0.777 | -0.133 | -5.186 | -20.69 | -1.881 | -0.046 | -0.041 | -0.033 |
| Netto Overnames
| 0 | -74.152 | 0 | 0 | 0 | 0 | 0 | -26.86 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | -12.5 | 0 | -17.5 | 0 | 0 | 0 | -62 | -105.999 | -19.999 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 74.152 | 0 | 0 | 0 | 0 | 0 | 62 | 105.999 | 0 | 1.5 | 0 |
| Overige Investeringsactiviteiten
| 0 | -74.152 | -5 | -17.5 | 0 | 0 | -0.75 | 1.75 | 0 | 0 | 1.5 | 3 |
| Kasstroom uit Investeringsactiviteiten
| 0 | -86.83 | -5.323 | -18.247 | -0.777 | -0.133 | -5.186 | -45.8 | -1.881 | -20.045 | 1.459 | 2.967 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 0 | -67.236 | -8 | -115 | -6 | -3.75 | -1.25 | 0 | 0 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 0 | 1.747 | 2.398 | 3.654 | 0.26 | 8.615 | 4.338 | 3.619 | 55.813 | 46.069 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | -18.004 | -21.213 | -34.999 | -17.961 | -73.105 | -43.792 | -37.003 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 0 | 79.031 | 0.821 | 112.129 | -0.264 | -11.262 | 53.146 | 3.333 | 55.813 | 0.085 | 9.809 | 9.548 |
| Kasstroom uit Financieringsactiviteiten
| 0 | -6.209 | -28.392 | -37.87 | -24.225 | -88.117 | 8.104 | -33.67 | 55.813 | 46.154 | 9.809 | 9.548 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| 30.797 | -42.338 | -5.496 | -6.62 | 30.984 | -35.866 | 61.837 | -26.263 | 44.214 | 12.266 | 5.389 | -3.033 |
| Kaspositie aan het Einde van de Periode
| 30.797 | 55.321 | 97.659 | 103.155 | 109.775 | 78.791 | 114.657 | 52.82 | 79.083 | 22.722 | 10.456 | 5.067 |